鴉片類藥物使用障礙 (OUD) 市場報告：趨勢、預測和競爭分析（至 2030 年）

鴉片類藥物使用障礙 (OUD) 趨勢和預測

全球鴉片類藥物使用障礙（OUD）市場的未來看起來充滿希望，醫院藥房和零售藥房市場充滿機會。到 2030 年，全球鴉片類藥物使用障礙 (OUD) 市場預計將達到 72 億美元，2024 年至 2030 年複合年成長率為 10.3%。這個市場的主要促進因素是癌症、心血管疾病、整形外科疾病等慢性疾病的盛行率不斷上升，人們越來越認知到Buprenornhine貼片是一種有效的治療選擇。

• 按藥物類型分類，Lucintel 預測，由於人口老化和鴉片類藥物濫用盛行率的增加，促效劑在預測期內仍將佔據很大一部分。
• 從分銷管道來看，由於政府在醫療保健基礎設施上的支出增加，醫院藥房將繼續成為一個重要的細分市場。
• 從地區來看，由於鴉片類藥物濫用治療藥物的上市和核准數量不斷增加，預計北美在預測期內仍將是最大的地區。

鴉片類藥物使用障礙 (OUD) 市場的策略性成長機會

鴉片類藥物使用障礙 (OUD) 市場在各種應用中提供了多種策略性成長機會。透過利用這些機會，我們可以改善治療結果、擴大可近性並有效解決持續的鴉片危機。

• 擴大 MAT 計劃：將戒毒治療援助計劃擴展到服務不足的地區可提供巨大的成長潛力。增加Buprenornhine和美沙酮等 MAT 選項可以改善 OUD 患者獲得有效治療的機會。
• 數位健康解決方案的整合：數位健康解決方案（包括遠端醫療和行動應用程式）的整合提供了成長機會。這些工具將增強治療服務、患者參與和監測，並為市場擴張開闢新途徑。
• 開發新治療方法：投資新治療方法的研究和開發，包括新藥物配方和聯合治療，提供了成長機會。解決未滿足需求的創新治療方法可以贏得市場佔有率並改善治療選擇。
• 擴大減少危害計畫：擴大有害物質減少計畫有成長機會，例如針頭交換服務和監督消費場所。這些計劃可以減少鴉片類藥物使用的影響，並提供治療和康復的途徑。
• 加強綜合護理模式：將 OUD 治療與心理健康和社會支持服務相結合的綜合護理模式的發展和實施提供了成長潛力。這些模型改善了患者的治療效果並滿足了 OUD 患者的多方面需求。

OUD 市場的策略性成長機會包括擴大 MAT 計畫、整合數位健康解決方案、開發新穎的治療方法、擴大危害減少舉措以及加強綜合護理模式。這些機會符合市場不斷變化的需求，可以推動治療和復原結果的顯著改善。

鴉片類藥物使用障礙 (OUD) 市場促進因素與挑戰

鴉片類藥物使用障礙 (OUD) 市場受到各種促進因素​​和挑戰的顯著影響，包括技術進步、經濟因素和監管變化。促進因素包括治療方案的創新、認知的提高、政策改革、經濟獎勵和改善治療的可近性。同時，挑戰包括監管障礙、經濟障礙以及治療依從性和可及性問題。了解這些因素對於尋求應對 OUD 市場複雜性並加強有效治療和管理策略的相關人員至關重要。

推動鴉片類藥物使用障礙（OUD）市場的因素是：

1.技術進步：數位健康工具和先進藥物處方等治療技術的創新正在推動OUD市場的成長。數位平台促進遠端監控、遠端醫療和個人化治療計劃，以提高患者參與度和治療結果。新的藥物配方，包括緩釋性方案，正在提高治療的有效性和便利性，並有助於不斷成長的市場需求。

2. 提高認知和教育：鴉片類藥物危機和對 OUD 認知的提高導致對有效治療的需求增加。教育宣傳活動和公共衛生工作正在增進對鴉片類藥物成癮的了解，減少恥辱並鼓勵治療。隨著越來越多的人意識到對 OUD 管理解決方案的需求，這種不斷成長的意識正在推動市場成長。

3. 政策和監管改革：透過政策和政策變化，獲得 OUD 待遇的機會有所改善。 《藥物輔助性治療(MAT) 保險覆蓋範圍擴大和支持法案》等政府措施正在減少治療障礙。這些改革鼓勵醫療保健提供者提供更廣泛的治療選擇，並改善患者的整體治療機會。

4. 財政獎勵和資金：政府和私人資金的增加正在支持 OUD 治療計劃和研究。經濟獎勵，例如對 MAT 的津貼和對成癮治療設施的津貼，使醫療保健提供者更容易提供全面治療。這種財政支持增加了治療方法的可用性和創新，並推動了市場成長。

5. 擴大獲得治療的機會：擴大 OUD 治療機會的努力，特別是在服務不足和農村地區，正在推動市場成長。增加治療中心數量、提供行動治療單位以及將治療納入初級衛生服務的努力正在改善可近性。這些努力正在幫助更多的人獲得管理 OUD 所需的護理。

鴉片類藥物使用疾患 (OUD) 市場面臨的挑戰包括：

1. 監管障礙：滿足複雜的監管要求並獲得新治療方法的核准可能很困難。地區法規的差異可能會延遲創新治療方法的市場進入，並為廣泛採用造成障礙。遵守嚴格的指導方針還會增加製造商的成本並限制治療方法的可用性。

2. 財務障礙：與 OUD 治療相關的高額費用（包括藥物和治療計劃）可能是一個重大障礙。財務限制可能會限制患者獲得所需治療並影響治療順從性。保險覆蓋範圍不足和自付費用可能會進一步加劇這些挑戰並影響整體市場成長。

3. 治療依從性和可近性問題：確保一致的治療順從性和解決可近性問題是主要挑戰。由於副作用、恥辱和缺乏支持，患者可能難以堅持治療。治療中心的可用性有限，尤其是在偏遠地區，也會阻礙治療中心的使用並影響 OUD 管理工作的有效性。

鴉片類藥物使用障礙市場是由市場促進因素和挑戰的複雜相互作用形成的。技術進步、認知提升、政策改革、經濟獎勵和擴大可及性是提高治療有效性和可近性的關鍵驅動力。然而，監管障礙、經濟障礙以及治療依從性和可近性問題構成了重大挑戰。解決這些因素對於最佳化市場策略和改善鴉片類藥物使用障礙患者的治療結果至關重要。了解和駕馭這些動態對於尋求推進 OUD 治療前景的相關人員至關重要。

目錄

第1章執行摘要

第2章全球鴉片類藥物使用障礙 (OUD) 市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 市場趨勢及預測分析（2018-2030）

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球鴉片類藥物使用障礙 (OUD) 市場趨勢 (2018-2023) 和預測 (2024-2030)
• 全球鴉片類藥物使用障礙 (OUD) 市場：按藥物類型
  • 促效劑
  • 拮抗劑
• 全球鴉片類藥物使用障礙 (OUD) 市場：按年齡層別
  • 19-39歲
  • 40-59歲
  • 60歲以上
• 全球鴉片類藥物使用障礙 (OUD) 市場：依給藥途徑
  • 口服
  • 靜脈
  • 舌下
• 全球鴉片類藥物使用障礙 (OUD) 市場：按分銷管道
  • 醫院藥房
  • 零售藥房

第4章 各地區市場趨勢及預測分析（2018-2030）

• 全球鴉片類藥物使用障礙 (OUD) 市場：按地區
• 北美鴉片類藥物使用疾患 (OUD) 市場
• 歐洲鴉片類藥物使用障礙 (OUD) 市場
• 亞太地區鴉片類藥物使用障礙 (OUD) 市場
• 其他地區鴉片類藥物使用障礙（OUD）市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球鴉片類藥物使用障礙 (OUD) 市場成長機會：按藥物類型
  • 全球鴉片類藥物使用障礙 (OUD) 市場成長機會：按年齡層別
  • 全球鴉片類藥物使用障礙 (OUD) 市場成長機會：按給藥途徑
  • 全球鴉片類藥物使用障礙 (OUD) 市場成長機會：按分銷管道
  • 全球鴉片類藥物使用障礙 (OUD) 市場成長機會：按地區
• 全球鴉片類藥物使用障礙 (OUD) 市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 全球鴉片類藥物使用障礙（OUD）市場容量擴張
  • 全球鴉片類藥物使用障礙 (OUD) 市場的企業合併(M&A) 和合資企業
  • 認證和許可

第7章主要企業簡介

• Hikma Pharmaceuticals
• Indivior
• Titan Pharmaceuticals
• Reckitt Benckiser Pharmaceuticals
• Camurus
• BioDelivery Sciences International
• Sandoz

Opioid Use Disorder (OUD) Trends and Forecast

The future of the global opioid use disorder (OUD) market looks promising with opportunities in the hospital pharmacy and retail pharmacy markets. The global opioid use disorder (OUD) market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are the growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and orthopedic diseases, and the increasing recognition of buprenorphine patches as an efficient treatment option.

• Lucintel forecasts that, within the drug type category, agonists will remain the larger segment over the forecast period due to the growing aging population and increase in the prevalence of opioid abuse.
• Within the distribution channel category, hospital pharmacies will remain the larger segment due to rising expenditure by the government to develop healthcare infrastructure.
• In terms of regions, North America will remain the largest region over the forecast period due to a rise in the number of product launches and product approval for opioid use disorder.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Opioid Use Disorder (OUD) Market

Emerging trends in the opioid use disorder (OUD) market are shaping the future of treatment with advancements in medication, technology, and holistic approaches. These trends reflect a shift towards more comprehensive and personalized care strategies.

• Increased Use of Digital Health Technologies: Digital health technologies

s, including telemedicine and mobile health apps, are being increasingly integrated into OUD treatment plans. These tools provide remote monitoring, virtual counseling, and personalized treatment adjustments, improving patient engagement and access to care.

• Advancements in Medication-Assisted Treatment (MAT): There have been significant innovations in MAT, including extended-release formulations and novel combination therapies. These advancements enhance treatment adherence and reduce the potential for misuse, offering more effective and long-lasting solutions for managing OUD.
• Focus on Integrated Care Models: Integrated care models that combine OUD treatment with mental health and social support services are gaining traction. This holistic approach addresses the multifaceted needs of patients, improving overall outcomes and reducing the risk of relapse.
• Expansion of Harm Reduction Programs: Harm reduction strategies, such as needle exchange programs and supervised consumption sites, are being expanded. These programs aim to reduce the negative health consequences of drug use and provide pathways to treatment and recovery.
• Emphasis on Personalized Medicine: Personalized medicine approaches, including genetic testing and individualized treatment plans, are becoming more prevalent. These strategies tailor treatment to the specific needs and characteristics of each patient, improving efficacy and minimizing side effects.

These emerging trends are reshaping the OUD market by introducing more effective, personalized, and integrated approaches to treatment. The focus on digital health, advanced medications, and holistic care models reflects a shift towards improving patient outcomes and addressing the complex needs of those affected by opioid use disorder.

Recent Developments in the Opioid Use Disorder (OUD) Market

Recent developments in the opioid use disorder (OUD) market have focused on improving treatment options, expanding access, and enhancing support systems. These changes are driven by the ongoing need to address the opioid crisis and provide effective, comprehensive care.

• Expansion of Medication-Assisted Treatment (MAT): New MAT formulations and extended-release options have been introduced, improving treatment adherence and efficacy. Innovations in buprenorphine and naltrexone formulations offer better management of withdrawal symptoms and relapse prevention.
• Integration of Digital Tools: The adoption of digital health tools, including telemedicine platforms and mobile apps, has enhanced the delivery of OUD treatment. These tools facilitate remote monitoring, virtual counseling, and data-driven adjustments to treatment plans.
• Strengthening Harm Reduction Initiatives: Governments and organizations have increased funding and support for harm reduction programs. Needle exchange programs, supervised consumption sites, and naloxone distribution efforts are expanding, aiming to reduce the negative impact of opioid use.
• Policy and Regulatory Changes: New regulations and policies have been implemented to improve access to OUD treatments and support services. Policies include expanded insurance coverage for MAT and initiatives to reduce stigma and increase public awareness.
• Focus on Integrated Care Models: Integrated care models that combine OUD treatment with mental health and social support services are being promoted. These models address the comprehensive needs of patients and enhance overall treatment effectiveness.

These recent developments reflect a concerted effort to improve OUD treatment and support systems. By focusing on medication advancements, digital tools, harm reduction, policy changes, and integrated care, the market is evolving to better address the complexities of opioid use disorder and support patient recovery.

Strategic Growth Opportunities for Opioid Use Disorder (OUD) Market

The opioid use disorder (OUD) market presents several strategic growth opportunities across various applications. Leveraging these opportunities can enhance treatment outcomes, expand access, and address the ongoing opioid crisis effectively.

• Expansion of MAT Programs: Expanding medication-assisted treatment programs to underserved areas offers significant growth potential. Increasing the availability of MAT options, such as buprenorphine and methadone, can improve access to effective treatment for those struggling with OUD.
• Integration of Digital Health Solutions: The incorporation of digital health solutions, including telemedicine and mobile apps, provides growth opportunities. These tools enhance treatment delivery, patient engagement, and monitoring, creating new avenues for market expansion.
• Development of Novel Therapies: Investing in research and development of novel therapies, such as new drug formulations and combination treatments, presents growth opportunities. Innovative therapies that address unmet needs can capture market share and offer improved treatment options.
• Expansion of Harm Reduction Programs: Expanding harm reduction programs, such as needle exchange services and supervised consumption sites, offers growth opportunities. These programs can reduce the impact of opioid use and provide pathways to treatment and recovery.
• Enhancement of Integrated Care Models: Developing and implementing integrated care models that combine OUD treatment with mental health and social support services presents growth potential. These models improve patient outcomes and address the multifaceted needs of individuals with OUD.

Strategic growth opportunities in the OUD market include expanding MAT programs, integrating digital health solutions, developing novel therapies, scaling harm reduction initiatives, and enhancing integrated care models. These opportunities align with the evolving needs of the market and can drive significant improvements in treatment and recovery outcomes.

Opioid Use Disorder (OUD) Market Driver and Challenges

The opioid use disorder (OUD) market is significantly influenced by various drivers and challenges that encompass technological advancements, economic factors, and regulatory changes. The drivers include innovations in treatment options, increased awareness, policy reforms, economic incentives, and improved access to care. Challenges, on the other hand, involve regulatory hurdles, economic barriers, and issues related to treatment adherence and accessibility. Understanding these factors is crucial for stakeholders aiming to navigate the complexities of the OUD market and enhance strategies for effective treatment and management.

The factors responsible for driving the opioid use disorder (OUD) market include:

1. Technological Advancements: Innovations in treatment technologies, such as digital health tools and advanced medication formulations, are driving growth in the OUD market. Digital platforms facilitate remote monitoring, telemedicine, and personalized treatment plans, improving patient engagement and outcomes. New drug formulations, including extended-release options, enhance the efficacy and convenience of treatment, contributing to increased market demand.

2. Increased Awareness and Education: Growing awareness about the opioid crisis and OUD has led to increased demand for effective treatments. Educational campaigns and public health initiatives are improving understanding of opioid addiction, reducing stigma, and encouraging individuals to seek treatment. This heightened awareness is driving market growth as more people recognize the need for OUD management solutions.

3. Policy and Regulatory Reforms: Changes in policies and regulations are facilitating better access to OUD treatments. Government initiatives, such as expanded insurance coverage for medication-assisted treatment (MAT) and supportive legislation, are reducing barriers to care. These reforms are encouraging healthcare providers to offer a wider range of treatment options and improving overall access for patients.

4. Economic Incentives and Funding: Increased funding from government and private sources is supporting OUD treatment programs and research. Economic incentives, such as subsidies for MAT and grants for addiction treatment facilities, are making it easier for providers to offer comprehensive care. This financial support is driving market growth by enhancing treatment availability and innovation.

5. Expansion of Treatment Access: Efforts to expand access to OUD treatments, particularly in underserved and rural areas, are driving market growth. Initiatives to increase the number of treatment centers, provide mobile treatment units, and integrate care into primary health services are improving accessibility. These efforts are ensuring that more individuals can receive the necessary care for managing OUD.

Challenges in the opioid use disorder (OUD) market include:

1. Regulatory Hurdles: Navigating complex regulatory requirements and obtaining approvals for new treatments can be challenging. Variability in regulations across regions can delay market entry for innovative therapies and create barriers to widespread adoption. Compliance with stringent guidelines can also increase costs for manufacturers and limit treatment availability.

2. Economic Barriers: High costs associated with OUD treatments, including medications and therapy programs, can be a significant barrier. Economic constraints may limit patient access to necessary care and affect treatment adherence. Insufficient insurance coverage and out-of-pocket expenses can further exacerbate these challenges, impacting overall market growth.

3. Treatment Adherence and Accessibility Issues: Ensuring consistent treatment adherence and addressing accessibility issues pose significant challenges. Patients may struggle with adherence due to side effects, stigma, or lack of support. Limited availability of treatment centers, particularly in remote areas, can also hinder access and affect the effectiveness of OUD management efforts.

The opioid use disorder market is shaped by a complex interplay of drivers and challenges. Technological advancements, increased awareness, policy reforms, economic incentives, and expanded access are key drivers that enhance treatment effectiveness and availability. However, regulatory hurdles, economic barriers, and issues with treatment adherence and accessibility present significant challenges. Addressing these factors is crucial for optimizing market strategies and improving outcomes for individuals affected by opioid use disorder. Understanding and navigating these dynamics will be essential for stakeholders seeking to advance the OUD treatment landscape.

List of Opioid Use Disorder (OUD) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies opioid use disorder (OUD) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the opioid use disorder (OUD) companies profiled in this report include-

• Hikma Pharmaceuticals
• Indivior
• Titan Pharmaceuticals
• Reckitt Benckiser Pharmaceuticals
• Camurus
• BioDelivery Sciences International
• Sandoz

Opioid Use Disorder (OUD) by Segment

The study includes a forecast for the global opioid use disorder (OUD) by drug type, age group, route of administration, distribution channel, and region.

Opioid Use Disorder (OUD) Market by Drug Type [Analysis by Value from 2018 to 2030]:

• Agonist
• Antagonist

Opioid Use Disorder (OUD) Market by Age Group [Analysis by Value from 2018 to 2030]:

• 19 To 39
• 40 To 59
• Age 60 and Over

List of Opioid Use Disorder (OUD) Companies

Opioid Use Disorder (OUD) Market by Route of Administration [Analysis by Value from 2018 to 2030]:

• Oral
• Intravenous
• Sublingual

Opioid Use Disorder (OUD) Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific

Opioid Use Disorder (OUD) Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail Pharmacy

Country Wise Outlook for the Opioid Use Disorder (OUD) Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below is a summary of recent developments by major opioid use disorder producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the US, there has been a notable increase in the availability of naloxone and buprenorphine, with expanded access through recent legislation. The FDA approved new formulations of buprenorphine for enhanced efficacy and ease of use. Additionally, federal and state governments are implementing comprehensive strategies, including expanded treatment facilities and harm reduction programs.
• China: China has been focusing on improving access to opioid dependence treatments, including methadone maintenance therapy (MMT) and buprenorphine. Recent policy changes have aimed to integrate OUD treatment into broader healthcare services. Efforts to increase public awareness and reduce stigma around addiction are also being emphasized.
• Germany: Germany has advanced its treatment protocols with new guidelines incorporating both pharmacological and psychosocial interventions. The integration of digital health solutions, such as telemedicine for therapy management, has been a key development. Increased funding for addiction treatment services has also been noted.
• India: In India, there is a growing focus on increasing access to OUD treatments, with an emphasis on expanding methadone and buprenorphine programs. Recent developments include the establishment of more treatment centers and community-based programs. Public awareness campaigns are being strengthened to combat stigma and promote treatment options.
• Japan: Japan has introduced new regulations to improve access to opioid treatment programs. There has been an increase in the availability of treatment options such as buprenorphine and extended-release naltrexone. Additionally, efforts to enhance coordination between healthcare providers and support systems have been a focus.

Features of the Global Opioid Use Disorder (OUD) Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the opioid use disorder (OUD) market by drug type (agonist and antagonist), age group (19 to 39, 40 to 59, and age 60 and over), route of administration (oral, intravenous, and sublingual), distribution channel (hospital pharmacy and retail pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Opioid Use Disorder (OUD) Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Opioid Use Disorder (OUD) Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Opioid Use Disorder (OUD) Market by Drug Type
  • 3.3.1: Agonist
  • 3.3.2: Antagonist
• 3.4: Global Opioid Use Disorder (OUD) Market by Age Group
  • 3.4.1: 19 to 39
  • 3.4.2: 40 to 59
  • 3.4.3: Age 60 and over
• 3.5: Global Opioid Use Disorder (OUD) Market by Route of Administration
  • 3.5.1: Oral
  • 3.5.2: Intravenous
  • 3.5.3: Sublingual
• 3.6: Global Opioid Use Disorder (OUD) Market by Distribution Channel
  • 3.6.1: Hospital pharmacy
  • 3.6.2: Retail Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Opioid Use Disorder (OUD) Market by Region
• 4.2: North American Opioid Use Disorder (OUD) Market
  • 4.2.1: North American Market by Drug Type: Agonist and Antagonist
  • 4.2.2: North American Market by Distribution Channel: Hospital pharmacy and Retail Pharmacy
• 4.3: European Opioid Use Disorder (OUD) Market
  • 4.3.1: European Market by Drug Type: Agonist and Antagonist
  • 4.3.2: European Market by Distribution Channel: Hospital pharmacy and Retail Pharmacy
• 4.4: APAC Opioid Use Disorder (OUD) Market
  • 4.4.1: APAC Market by Drug Type: Agonist and Antagonist
  • 4.4.2: APAC Market by Distribution Channel: Hospital pharmacy and Retail Pharmacy
• 4.5: ROW Opioid Use Disorder (OUD) Market
  • 4.5.1: ROW Market by Drug Type: Agonist and Antagonist
  • 4.5.2: ROW Market by Distribution Channel: Hospital pharmacy and Retail Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Opioid Use Disorder (OUD) Market by Drug Type
  • 6.1.2: Growth Opportunities for the Global Opioid Use Disorder (OUD) Market by Age Group
  • 6.1.3: Growth Opportunities for the Global Opioid Use Disorder (OUD) Market by Route of Administration
  • 6.1.4: Growth Opportunities for the Global Opioid Use Disorder (OUD) Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Opioid Use Disorder (OUD) Market by Region
• 6.2: Emerging Trends in the Global Opioid Use Disorder (OUD) Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Opioid Use Disorder (OUD) Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Opioid Use Disorder (OUD) Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hikma Pharmaceuticals
• 7.2: Indivior
• 7.3: Titan Pharmaceuticals
• 7.4: Reckitt Benckiser Pharmaceuticals
• 7.5: Camurus
• 7.6: BioDelivery Sciences International
• 7.7: Sandoz